Please wait a minute...
Reviews in Cardiovascular Medicine  2020, Vol. 21 Issue (1): 1-7     DOI: 10.31083/j.rcm.2020.01.42
News and Views | Next articles
Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection
Peter A. McCullough1, 2, 3, *(), John Eidt1, 2, 3, Janani Rangaswami4, Edgar Lerma5, James Tumlin6, Kevin Wheelan1, 2, 3, Nevin Katz7, Norman E. Lepor8, Kris Vijay9, Sandeep Soman10, Bhupinder Singh11, Sean P. McCullough12, Haley B. McCullough13, Alberto Palazzuoli14, Gaetano M. Ruocco14, Claudio Ronco15, 16
Baylor University Medical Center, Dallas, TX 75226, USA
Baylor Heart and Vascular Institute, Dallas, TX 75226, USA
Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, TX 75226, USA
Thomas Jefferson College of Medicine, Einstein Medical Center, Philadelphia, PA 19141, USA
University of Illinois at Chicago, Advocate Christ Medical Center Oak Lawn, IL 60453, USA
Emory University School of Medicine, Atlanta, GA 30322, USA
Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
Abrazo Arizona Heart Hospital and Heart Institute in Phoenix, AZ 850169, USA
10 Henry Ford Hospital Detroit, MI 48202, USA
11 Cardiorenal Society of America, Phoenix, AZ 85004, USA
12 University of Texas McGovern Medical School, Houston, TX 77030, USA
13 University of Denver Sturm School of Law, Denver, CO 80210, USA
14 University of Siena, Le Scotte Hospital Viale Bracci Siena Italy, Siena, SI 53100, Italy.
15 Università degli Studi di Padova, PD 35122, Italy
16 University of Padova, Padova, International Renal Research Institute Vicenza, San Bortolo Hospital, Vicenza, VI 36100, Italy
Download:  PDF(1140KB)  ( 3236 ) Full text   ( 122 )
Export:  BibTeX | EndNote (RIS)      

Approximately 90 days of the SARS-CoV-2 (COVID-19) spreading originally from Wuhan, China, and across the globe has led to a widespread chain of events with imminent threats to the fragile relationship between community health and economic health. Despite near hourly reporting on this crisis, there has been no regular, updated, or accurate reporting of hospitalizations for COVID-19. It is known that many test-positive individuals may not develop symptoms or have a mild self-limited viral syndrome consisting of fever, malaise, dry cough, and constitutional symptoms. However some individuals develop a more fulminant syndrome including viral pneumonia, respiratory failure requiring oxygen, acute respiratory distress syndrome requiring mechanical ventilation, and in substantial fractions leading to death attributable to COVID-19. The pandemic is evolving in a clustered, non-inform fashion resulting in many hospitals with preparedness but few or no cases, and others that are completely overwhelmed. Thus, a considerable risk of spread when personal protection equipment becomes exhausted and a large fraction of mortality in those not offered mechanical ventilation are both attributable to a crisis due to maldistribution of resources. The pandemic is amenable to self-reporting through a mobile phone application that could obtain critical information on suspected cases and report on the results of self testing and actions taken. The only method to understand the clustering and the immediate hospital resource needs is mandatory, uniform, daily reporting of hospital censuses of COVID-19 cases admitted to hospital wards and intensive care units. Current reports of hospitalizations are delayed, uncertain, and wholly inadequate. This paper urges all the relevant stakeholders to take up self-reporting and reporting of hospitalizations of COVID-19 as an urgent task in combating this devastating pandemic.

Key words:  SARS-CoV-2      COVID-19      hospitalization      critical care      mortality      epidemiology      reporting      public health      resource utilization     
Submitted:  23 March 2020      Accepted:  24 March 2020      Published:  30 March 2020     
*Corresponding Author(s):  Peter A. McCullough     E-mail:

Cite this article: 

Peter A. McCullough, John Eidt, Janani Rangaswami, Edgar Lerma, James Tumlin, Kevin Wheelan, Nevin Katz, Norman E. Lepor, Kris Vijay, Sandeep Soman, Bhupinder Singh, Sean P. McCullough, Haley B. McCullough, Alberto Palazzuoli, Gaetano M. Ruocco, Claudio Ronco. Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection. Reviews in Cardiovascular Medicine, 2020, 21(1): 1-7.

URL:     OR

Table 1.  Various internet reporting of the COVID-19 pandemic. These sources are commonly taken and redisplayed in the television and other news media.
SourceWeb Site URLsInformation ReportedSources of InformationInformation not Reported
Centers for Disease Control and Prevention
1.Total cases
2.Total deaths
4.ICU admissions
10 different sourcesa1.Self-reported cases
Johns Hopkins University & Medicine cases
2.Total deaths
3.Total recovered
1.DXY (online platform run by members of the Chinese medical community);
2.China CDC (CCDC),
3.Hong Kong Department of Health,
4.Macau Government,
5.Taiwan CDC,
6.European CDC (ECDC)
7.World Health Organization (WHO)
9.Government of Canada
10.Australia Government Department of Health
11.Various state or territory health authorities
1.Self-reported cases
3.ICU admissions
Worldometerb cases
2.Total deaths
3.Total recovered
4.Infected patients in mild condition; serious/critical condition
5.Total Recovered
25 different sourcesc including press reports and social media reporting1.Self-reported cases
3.ICU admissions
World Health Organization
1.Total cases
2.Total deaths
3.Transmission classification
National authorities (no specific sources stated)1.Self-reported cases
3.ICU admissions
Figure 1.  Sample report access from the Johns Hopkins website on March 23, 2020

Figure 2.  Sample report of hospitalized cases from the CDC website on March 22, 2020, data unchanged since March 16, 2020

Figure 3.  Sample report of all information reported on Worldmeter accessed March 23, 2020

[1] Adhikari, S. P.,Meng, S.,Wu, Y.-J.,Mao, Y.-P.,Ye, R.-X.,Wang, Q.-Z.,Sun, C.,Sylvia, S.,Rozelle, S.,Raat, H. and Zhou, H. (2020)Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review.Infectious Diseases of Poverty 9, 29.
[2] Centers for Disease, Control andPrevention (2020)Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12-March 16, 2020.MMWR: Morbidity and Mortality Weekly Report 69, 343-346. DOI:
[3] Phelan, A. L.,Katz, R. and Gostin, L. O. (2020) The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance.JAMA 323, 709-710.
[4] World Health, Organization (2020a) Coronavirus disease (COVID-2019): situation reports: 55. March 15, 2020. Available at: (accessed March 16, 2020).
[5] World Health Organization (2020b)WHO Virtual press conference on COVID-19. March 11, 2020. Available at: (accessed March 16, 2020).
[1] Yin-jun Mao, Hang Wang, Jian-xing Chen, Pin-fang Huang. Meta-analysis of medical management versus catheter ablation for atrial fibrillation[J]. Reviews in Cardiovascular Medicine, 2020, 21(3): 419-432.
[2] Niloofar Deravi, Mobina Fathi, Kimia Vakili, Shirin Yaghoobpoor, Marzieh Pirzadeh, Melika Mokhtari, Tara Fazel, Elahe Ahsan, Samad Ghaffari. SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review[J]. Reviews in Cardiovascular Medicine, 2020, 21(3): 385-397.
[3] Ramesh K. Goyal, Jaseela Majeed, Rajiv Tonk, Mahaveer Dhobi, Bhoomika Patel, Kalicharan Sharma, Subbu Apparsundaram. Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection[J]. Reviews in Cardiovascular Medicine, 2020, 21(3): 365-384.
[4] Jun Zhang, Kristen M. Tecson, Peter A. McCullough. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy[J]. Reviews in Cardiovascular Medicine, 2020, 21(3): 315-319.
[5] Jun Zhang, Peter A. McCullough, Kristen M. Tecson. Vitamin D deficiency in association with endothelial dysfunction: Implications for patients withCOVID-19[J]. Reviews in Cardiovascular Medicine, 2020, 21(3): 339-344.
[6] Allison Zimmerman, Dinesh Kalra. Usefulness of machine learning in COVID-19 for the detection and prognosis of cardiovascular complications[J]. Reviews in Cardiovascular Medicine, 2020, 21(3): 345-352.
[7] Ajay K. Mahenthiran, Ashorne K. Mahenthiran, Jo Mahenthiran. Cardiovascular system and COVID-19: manifestations and therapeutics[J]. Reviews in Cardiovascular Medicine, 2020, 21(3): 399-409.
[8] Kimia Vakili, Mobina Fathi, Aiyoub Pezeshgi, Ashraf Mohamadkhani, Mohammadreza Hajiesmaeili, Mostafa Rezaei-Tavirani, Fatemeh Sayehmiri. Critical complications of COVID-19: A descriptive meta-analysis study[J]. Reviews in Cardiovascular Medicine, 2020, 21(3): 433-442.
[9] Matteo Cameli, Maria Concetta Pastore, Michael Henein, Hatem Soliman Aboumarie, Giulia Elena Mandoli, Flavio D'Ascenzi, Paolo Cameli, Federico Franchi, Sergio Mondillo, Serafina Valente. Safe performance of echocardiography during the COVID-19 pandemic: a practical guide[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 217-223.
[10] Gayatri Setia, Jeffrey Tyler, Alan Kwan, Josh Faguet, Shilpa Sharma, Siddharth Singh, Babak Azarbal, Rose Tompkins, Dinora Chinchilla, Sara Ghandehari. High thrombus burden despite thrombolytic therapy in ST-elevation myocardial infarction in a patient with COVID-19[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 289-295.
[11] Akanksha Agrawal, Hafeez Ul Hassan Virk, Iqra Riaz, Deepanshu Jain, Byomesh Tripathi, Chayakrit Krittanawong, Benham Bozorgnia, Vincent Figueredo, Peter A. McCullough, Janani Rangaswami. Predictors of 30-day re-admissions in patients with infective endocarditis: a national population based cohort study[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 123-127.
[12] Michele Provenzano, Giuseppe Coppolino, Teresa Faga, Carlo Garofalo, Raffaele Serra, Michele Andreucci. Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer[J]. Reviews in Cardiovascular Medicine, 2019, 20(4): 209-220.
[13] Wan Chin Hsieh, Anas Aboud, Brandon M. chael Henry, Mohamed Omara, Jaroslav Lindner, Jan Pirk. Serum albumin in patients undergoing transcatheter aortic valve replacement: A meta-analysis[J]. Reviews in Cardiovascular Medicine, 2019, 20(3): 161-169.
[14] Davide Bolignano, Anna Pisano, Graziella D’Arrigo. Pulmonary hypertension: a neglected risk condition in renal patients?[J]. Reviews in Cardiovascular Medicine, 2018, 19(4): 117-121.
[15] Nasrien E. Ibrahim, Akshay S. Desai, Jagmeet P. Singh, James L. Januzzi Jr. Advances in Heart Failure Management: Improving Outcomes With Innovation[J]. Reviews in Cardiovascular Medicine, 2017, 18(S1): 1-16.
No Suggested Reading articles found!